Press News

Press News

Press News | 27.02.2025

Print:
Title Media Publ. Date
A national strategic support for rare patients is necessary Daily PharmaNews 26/02/2025
Clinical Trials: An investment with multiple and substantial benefits Anaptyxi ΕΒΕΑ 01/02/2025
Appointment in medicine canceled after reactions Kathimerini 27/02/2025
Employers propose a gross minimum wage of up to €871.50 Naftemporiki 27/02/2025

 

See here the publicity

 

Web Monitoring Report for the period 26/02- 27/02

Title Media Publ. Date
National Program “PROLAMVANO” for cardiovascular diseases: 5.2 million beneficiaries – First SMS sent today cnn.gr 26/02/2025
Doses of vaccines are lost where a pharmacist is not involved farmakeutikoskosmos.gr 27/02/2025
SFEE: New study on diabetes and the healthcare system healthpharma.gr 27/02/2025
Problem with personal data in the transfer of digital medical records iatronet.gr 27/02/2025
Catastrophic health expenses for 1 in 10 households in Greece – The country ranks first in depression insider.gr 27/02/2025
Adonis Georgiadis visited the pharmaceutical companies ABBVIE and SANOFI news4health.gr 26/02/2025
The rare liver disease diagnosed at 55 – Treatment in chronic shortage ygeiamou.gr 27/02/2025
The importance of prevention and proactive screening for diseases affecting 500,000 people in Greece ygeiamou.gr 27/02/2025
Rareland: A Film About Rare Diseases – The Screenwriter Speaks to ygeiamou ygeiamou.gr 26/02/2025
The challenges in diagnosing and treating rare diseases – 40% of patients are initially misdiagnosed ygeiamou.gr 26/02/2025

RELATED NEWS

Skip to content
SFEE
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.